The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Glucocorticoid‐induced hyperglycemia (糖皮质激素诱导的高血糖)
Abstract
Corticosteroid‐induced hyperglycemia is a common medical problem that can lead to frequent emergency room visits, hospital admissions and prolonged hospital stay, in addition to the well known morbidity associated with hyperglycemia. However, the diagnosis and treatment of corticosteroid‐induced hyperglycemia is surprisingly undervalued by most professionals, probably because of the lack of quality studies to determine specific strategies of action. In the present review, we discuss the pathophysiology of corticosteroid‐induced hyperglycemia, focusing on diverse patterns of hyperglycemia induced by the different formulations, and provide clues for diagnosis based on the duration of treatment and the administration schedule of corticosteroids. We propose a treatment strategy based on both the pathophysiology of the process and the mechanism of action of different corticosteroids, and take into account dosing and administration timing to predict the duration of therapy. Finally, we propose treatment goals that differ slightly between the transient and continuous use of corticosteroids based on evidence from clinical practice guidelines of diabetes care both in ambulatory and hospital settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Management of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731 · cited 2×
“Corticosteroids increase endogenous glucose production directly by activating numerous genes involved in the hepatic metabolism of carbohydrates, leading to an increment in gluconeogenesis, especially phosphoenolpyruvate carboxykinase and glucose-6-phosphatase, as well as indirectly by antagonizing the metabolic actio…”
BackgroundUmpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M. (2011) · Diabetes Care · doi:10.2337/dc10-1407 · Cited by 720
RIZZA, R. A., MANDARINO, L. J., & GERICH, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-131 · Cited by 696 · cited 2×
“In adipose tissue, corticosteroids increase lipolysis,(70) leading to increased plasma levels of non-sterified fatty acids, which accumulate within muscle cells and reduce glucose uptake by interfering with insulin signaling.(15,40) Costicosteroids also inhibit the production and secretion of insulin from pancreatic β…”
BackgroundHermansen, K., Davies, M., Derezinski, T., Martinez Ravn, G., Clauson, P., Home, P., & on behalf of the Levemir Treat-to-Target Study Group (2006) · Diabetes Care · doi:10.2337/dc05-1365 · Cited by 627
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Glucocorticoid-induced hyperglycemia
Clore, J. N., & Thurby-Hay, L. (2009) · Endocrine Practice · doi:10.4158/ep08331.rar · Cited by 508
Sasaki, K., Cripe, T. P., Koch, S. R., Andreone, T. L., Petersen, D. D., Beale, E. G., & Granner, D. K. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42541-5 · Cited by 428
Lambillotte, C., Gilon, P., & Henquin, J. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119175 · Cited by 419
Effects of glucocorticoids on carbohydrate metabolism
Mcmahon, M., Gerich, J., & Rizza, R. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040105 · Cited by 390
Hormonal regulation of hepatic gluconeogenesis.
Kraus-Friedmann, N. (1984) · Physiological Reviews · doi:10.1152/physrev.1984.64.1.170 · Cited by 276 · cited 1×
“In addition, corticosteroids may enhance the effects of other counterregulatory hormones, such as glucagon and epinephrine, which increase the endogenous synthesis of glucose.(48,50) It has also been shown that the expression of the nuclear receptor peroxisome proliferator-activated receptor (PPAR) α is necessary for…”
BackgroundDIMITRIADIS, G., LEIGHTON, B., PARRY-BILLINGS, M., SASSON, S., YOUNG, M., KRAUSE, U., BEVAN, S., PIVA, T., WEGENER, G., & NEWSHOLME, E. A. (1997) · Biochemical Journal · doi:10.1042/bj3210707 · Cited by 266
Pagano, G., Cavallo-Perin, P., Cassader, M., Bruno, A., Ozzello, A., Masciola, P., Dall'omo, A. M., & Imbimbo, B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111141 · Cited by 259
Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients
Donihi, A. C., Raval, D., Saul, M., Korytkowski, M. T., & DeVita, M. A. (2006) · Endocrine Practice · doi:10.4158/ep.12.4.358 · Cited by 246 · cited 1×
“The incidence of hyperglycemia (defined as blood glucose >200 mg/dL) in hospitalized patients without a known history of diabetes and treated with corticosteroids is >50%.(8) Up to 40% of patients with neuropathy without a known glycemic disorder developed diabetes after taking corticosteroids(9) and, in patients with…”
BackgroundRuzzin, J., Wagman, A. S., & Jensen, J. (2005) · Diabetologia · doi:10.1007/s00125-005-1886-0 · Cited by 243
Insulin resistance and impaired beta cell function in rheumatoid arthritis
Dessein, P. H., & Joffe, B. I. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22053 · Cited by 218 · cited 1×
“Data available from patients who take corticosteroids chronically in clinical practice do not provide reliable results, because the indication for treatment is often due to systemic inflammatory processes that can also affect β-cell function.(80) It has been postulated that a proapoptotic effect of corticosteroids(25)…”
BackgroundRisk of Diabetes Associated With Prescribed Glucocorticoids in a Large Population
Gulliford, M. C., Charlton, J., & Latinovic, R. (2006) · Diabetes Care · doi:10.2337/dc06-1499 · Cited by 211
Stimulation of Lipolysis in Humans by Physiological Hypercortisolemia
Divertie, G. D., Jensen, M. D., & Miles, J. M. (1991) · Diabetes · doi:10.2337/diab.40.10.1228 · Cited by 201
Acute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men
van Raalte, D. H., Nofrate, V., Bunck, M. C., van Iersel, T., Elassaiss Schaap, J., Nässander, U. K., Heine, R. J., Mari, A., Dokter, W. H. A., & Diamant, M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-1034 · Cited by 170
Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases
Uzu, T., Harada, T., Sakaguchi, M., Kanasaki, M., Isshiki, K., Araki, S., Sugiomoto, T., Koya, D., Haneda, M., Kashiwagi, A., et al. (2006) · Nephron Clinical Practice · doi:10.1159/000097598 · Cited by 136
Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race
Magee, M. H., Blum, R. A., Lates, C. D., & Jusko, W. J. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122012733 · Cited by 125
Alford, F., Beck-Nielsen, H., Ward, G. M., & Henriksen, J. E. (1997) · Diabetologia · doi:10.1007/s001250050847 · Cited by 115
KALHAN, S. C., & ADAM, P. A. J. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-3-600 · Cited by 94
Grill, V., Pigon, J., Hartling, S. G., Binder, C., & Efendic, S. (1990) · Metabolism · doi:10.1016/0026-0495(90)90043-c · Cited by 78
Larsson, H., & Ahrén, B. (1999) · Diabetologia · doi:10.1007/s001250051251 · Cited by 73
Jeong, I.-K., Oh, S.-H., Kim, B.-J., Chung, J.-H., Min, Y.-K., Lee, M.-S., Lee, M.-K., & Kim, K.-W. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00229-1 · Cited by 71
Nielsen, M. F., Caumo, A., Chandramouli, V., Schumann, W. C., Cobelli, C., Landau, B. R., Vilstrup, H., Rizza, R. A., & Schmitz, O. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00566.2002 · Cited by 53 · cited 1×
“The increase in the liver production of glucose induced by corticosteroids is higher in the postprandial period.(52) Corticosteroids reduce peripheral glucose uptake at the level of the muscle and adipose tissue.”
BackgroundHenriksen, J. E., Alford, F., Vaag, A., Handberg, A., & Beck-Nielsen, H. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90126-9 · Cited by 33
Cited by
Teprotumumab for the Treatment of Active Thyroid Eye Disease
Douglas, R. S., Kahaly, G. J., Patel, A., Sile, S., Thompson, E. H. Z., Perdok, R., Fleming, J. C., Fowler, B. T., Marcocci, C., Marinò, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910434 · Cited by 752
Tamez-Pérez, H. E. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i8.1073 · Cited by 387
Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance
Beaupere, C., Liboz, A., Fève, B., Blondeau, B., & Guillemain, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020623 · Cited by 271
“Patients undergoing chronic or prolonged oral/intravenous corticotherapy should be closely monitored as it may lead to hyperglycemia over time [20].”
Background9. pharmacologic approaches to glycemic treatment: standards of care in diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s009 · Cited by 263
Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions
Li, J.-X., & Cummins, C. L. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00683-6 · Cited by 257
Metadata
- Authors
- Perez, A., Jansen‐Chaparro, S., Saigi, I., Bernal‐Lopez, M. R., Miñambres, I., & Gomez‐Huelgas, R.
- Venue
- Journal of Diabetes
- Publisher
- Wiley
- Published
- 2013-10-29
- Volume
- 6
- Issue
- 1
- Pages
- 9-20
- ISSN
- 1753-0393 (ISSN-L)
- 1753-0407
- OpenAlex
- W2114348148
- Cited by
- 240
- References
- 29
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.